Intravenous thrombolysis with recombinant tissue plasminogen activator (r-tPA) was recommended for acute ischemic stroke (AIS) patients within 4.5 h of stroke onset, and an increasing trend of r-tPA treatment was discovered over the past 13 years ( 2 ).
← all excerpts
Eosinophil-to-Neutrophil Ratio Predicts Poor Prognosis of Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.
1
—
—